Variant report
Variant | esv1824806 |
---|---|
Chromosome Location | chr6:32319364-32325138 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:18)
- CpG islands (count:184)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:18 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr6:32321136-32321610 | Hela-S3 | cervix: | n/a | n/a |
2 | EP300 | chr6:32321139-32321500 | Hela-S3 | cervix: | n/a | n/a |
3 | FOS | chr6:32321122-32321561 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr6:32321184-32321501 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr6:32321132-32321502 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr6:32321115-32321505 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | GATA2 | chr6:32323035-32323624 | HUVEC | blood vessel: | n/a | n/a |
8 | MYC | chr6:32321278-32321564 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | POLR2A | chr6:32324354-32324363 | MCF-7 | breast: | n/a | n/a |
10 | POLR2A | chr6:32324969-32325114 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | POLR2A | chr6:32324366-32324388 | MCF-7 | breast: | n/a | n/a |
12 | PRDM1 | chr6:32323220-32323427 | Hela-S3 | cervix: | n/a | n/a |
13 | STAT3 | chr6:32321347-32321420 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | STAT3 | chr6:32321165-32321481 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | STAT3 | chr6:32321069-32321546 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | STAT3 | chr6:32321140-32321480 | Hela-S3 | cervix: | n/a | n/a |
17 | STAT3 | chr6:32321157-32321514 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | STAT3 | chr6:32319840-32319996 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:32320715-32320765 | RPTEC | kidney: | n/a |
2 | chr6:32320715-32320765 | RPTEC | kidney: | n/a |
3 | chr6:32320708-32320758 | Caco-2 | colon: | n/a |
4 | chr6:32324878-32324928 | Hepatocyte | liver: | n/a |
5 | chr6:32324878-32324928 | SK-N-MC | brain: | n/a |
6 | chr6:32324878-32324928 | ovcar-3 | ovarian: | n/a |
7 | chr6:32324878-32324928 | Jurkat | blood: | n/a |
8 | chr6:32320708-32320758 | GM12892 | blood: | n/a |
9 | chr6:32320715-32320765 | GM12891 | blood: | n/a |
10 | chr6:32324878-32324928 | HRCEpiC | kidney: | n/a |
11 | chr6:32320708-32320758 | PFSK-1 | brain: | n/a |
12 | chr6:32320715-32320765 | SK-N-MC | brain: | n/a |
13 | chr6:32320715-32320765 | LNCaP | prostate: | n/a |
14 | chr6:32320715-32320765 | PFSK-1 | brain: | n/a |
15 | chr6:32320715-32320765 | HepG2 | liver: | n/a |
16 | chr6:32324878-32324928 | T-47D | breast: | n/a |
17 | chr6:32320715-32320765 | SK-N-SH_RA | brain: | n/a |
18 | chr6:32320708-32320758 | PrEC | prostate: | n/a |
19 | chr6:32320708-32320758 | A549 | lung: | n/a |
20 | chr6:32320715-32320765 | NB4 | blood: | n/a |
21 | chr6:32324878-32324928 | HEK293 | kidney: | embryo |
22 | chr6:32324878-32324928 | HUVEC | blood vessel: | n/a |
23 | chr6:32324878-32324928 | BJ | skin: | n/a |
24 | chr6:32324878-32324928 | SAEC | small airway: | n/a |
25 | chr6:32320708-32320758 | MCF10A-Er-Src | breast: | n/a |
26 | chr6:32324878-32324928 | HPAEpiC | pulmonary alveolar: | n/a |
27 | chr6:32320708-32320758 | SK-N-SH_RA | brain: | n/a |
28 | chr6:32324878-32324928 | GM12892 | blood: | n/a |
29 | chr6:32320715-32320765 | GM06990 | blood: | n/a |
30 | chr6:32320708-32320758 | Hela-S3 | cervix: | n/a |
31 | chr6:32320715-32320765 | H1-hESC | embryonic stem cell: | embryo |
32 | chr6:32320708-32320758 | GM06990 | blood: | n/a |
33 | chr6:32320708-32320758 | NHBE | bronchial: | n/a |
34 | chr6:32320708-32320758 | NHDF-neo | bronchial: | n/a |
35 | chr6:32320708-32320758 | GM12891 | blood: | n/a |
36 | chr6:32320708-32320758 | HL-60 | blood: | n/a |
37 | chr6:32320715-32320765 | MCF-7 | breast: | n/a |
38 | chr6:32320715-32320765 | ECC-1 | luminal epithelium: | n/a |
39 | chr6:32320708-32320758 | AG10803 | skin: | n/a |
40 | chr6:32324878-32324928 | AG04450 | lung: | fetal |
41 | chr6:32320715-32320765 | A549 | lung: | n/a |
42 | chr6:32320708-32320758 | PANC-1 | pancreas: | n/a |
43 | chr6:32320715-32320765 | BJ | skin: | n/a |
44 | chr6:32320708-32320758 | HUVEC | blood vessel: | n/a |
45 | chr6:32324878-32324928 | LNCaP | prostate: | n/a |
46 | chr6:32324878-32324928 | BE2_C | brain: | n/a |
47 | chr6:32320715-32320765 | SAEC | small airway: | n/a |
48 | chr6:32320715-32320765 | HCT-116 | colon: | n/a |
49 | chr6:32320715-32320765 | NHBE | bronchial: | n/a |
50 | chr6:32320715-32320765 | AG09309 | skin: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-603P | TF binding region |
RNU6-603P | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3117118 | chr6:32319387-32319388 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs147712241 | chr6:32319412-32319413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs371150666 | chr6:32319496-32319497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575778818 | chr6:32319502-32319503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9268301 | chr6:32319637-32319638 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundancedisease |
6 | rs561138267 | chr6:32319640-32319641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184007518 | chr6:32319674-32319675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs59880608 | chr6:32319798-32319799 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs554550910 | chr6:32319840-32319841 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs572754489 | chr6:32319908-32319909 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs536881854 | chr6:32320112-32320113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs3132963 | chr6:32320153-32320154 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs145686540 | chr6:32320221-32320222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186022348 | chr6:32320278-32320279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190837971 | chr6:32320283-32320284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183156403 | chr6:32320370-32320371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187179932 | chr6:32320394-32320395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs191988280 | chr6:32320417-32320418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs369223770 | chr6:32320546-32320547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182991405 | chr6:32320554-32320555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560054176 | chr6:32320622-32320623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141669711 | chr6:32320709-32320710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187666528 | chr6:32320715-32320716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs147053349 | chr6:32320716-32320717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534284355 | chr6:32320721-32320722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138501651 | chr6:32320734-32320735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115271585 | chr6:32320787-32320788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs200497212 | chr6:32320803-32320804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73396970 | chr6:32320814-32320815 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs544732510 | chr6:32320959-32320960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2022544 | chr6:32321004-32321005 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs185626728 | chr6:32321037-32321038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573844682 | chr6:32321122-32321123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs114928941 | chr6:32321169-32321170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs9501614 | chr6:32321201-32321202 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs189350851 | chr6:32321231-32321232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs114729388 | chr6:32321262-32321263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs3117117 | chr6:32321272-32321273 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs114102860 | chr6:32321302-32321303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553370672 | chr6:32321371-32321372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs527573865 | chr6:32321392-32321393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs201946611 | chr6:32321413-32321414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200715101 | chr6:32321421-32321422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs3038511 | chr6:32321425-32321426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs192341285 | chr6:32321458-32321459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs368529276 | chr6:32321473-32321474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142516848 | chr6:32321511-32321512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184721580 | chr6:32321519-32321520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543229349 | chr6:32321548-32321549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs2395148 | chr6:32321554-32321555 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundancedisease |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22844521 | CNVD |
Gestational infection | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Incontinentia Pigmenti | 22033527 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Encephalopathy | 20692195 | CNVD |
Immune disease | 17576883 | CNVD |
Multiple myeloma | 16616336 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:32317800-32320800 | Weak transcription | Hela-S3 | cervix |
2 | chr6:32320800-32321800 | Enhancers | Hela-S3 | cervix |
3 | chr6:32320800-32322000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr6:32321800-32323000 | Weak transcription | Hela-S3 | cervix |
5 | chr6:32322000-32323200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr6:32322800-32323600 | Enhancers | HUVEC | blood vessel |
7 | chr6:32323000-32323400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr6:32323000-32324200 | Enhancers | Hela-S3 | cervix |
9 | chr6:32323200-32324000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr6:32324200-32324600 | Weak transcription | Hela-S3 | cervix |
11 | chr6:32324600-32325600 | Enhancers | Hela-S3 | cervix |